NOKOMIS, Fla.--(BUSINESS WIRE)--Rainbow BioSciences, a division of Rainbow Coral Corp. (OTCBB:RBCC), announced today that the company is moving forward with a term sheet to be presented to the emerging Parkinson’s drug therapy company that it is targeting for a potential relationship.
The term sheet will be the first step in a new business relationship with the promising early-stage company, which is prepping a new therapeutic protein for Parkinson’s for clinical trials. In addition to potentially meeting a key unmet medical need in a $3 billion market, the product could usher in new development opportunities accessing markets in excess of $100 billion.
RBCC has targeted the emerging company as part of its strategy to collaborate with drug and technology innovators to capitalize on the booming global market for emerging biotech health solutions. The company expects to announce the signed term sheet in the coming days.
RBCC continues to discuss deals with other emerging biotech innovators, as well. For more information on RBCC’s biotechnology initiatives, please visit www.rainbowbiosciences.com/investors.
About Rainbow BioSciences
Rainbow BioSciences, LLC, is a wholly owned subsidiary of Rainbow Coral Corp. (OTCBB: RBCC). The company continually seeks out new partnerships with biotechnology developers to deliver profitable new medical technologies and innovations. For more information on our growth-oriented business initiatives, please visit our website at [www.RainbowBioSciences.com]. For investment information and performance data on the company, please visit www.RainbowBioSciences.com/investors.
Notice Regarding Forward-Looking Statements
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipate" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone's past success, either financial or strategic, is no guarantee of future success. This news release speaks as of the date first set forth above and the company assumes no responsibility to update the information included herein for events occurring after the date hereof.